Virarazer (EFAVIRENZ 600 mg + EMTRICITABINE 200 mg + TENOFOVIR DISOPROXIL FUMARATE 300 mg) x 30 Tablets

Benefits of EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

• Helps lower HIV viral load
• Supports daily HIV management
• Strengthens immune system response
• Helps slow HIV progression
• Used in combination HIV therapy
• Improves overall treatment outcomes

Side Effects

• Headache
• Nausea
• Dizziness
• Insomnia
• Fatigue

Caution:

• Take as prescribed, once daily at bedtime.
• Do not skip or stop doses.
• Inform your doctor of liver or kidney issues.
• Monitor liver and kidney function.
• Avoid alcohol.
• Do not share medication.
• Store in a cool, dry place, away from children.

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Price and Reimbursement Information by Country

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.

• View medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/drugs/efavirenz-with-emtricitabine-and-tenofovir-disoproxil/medicinal-forms/
• View medicine and cost information on Drugs.com (USA) – https://www.drugs.com/compare/efavirenz-emtricitabine-tenofovir-disoproxil
• View patient medicine information on HIV.gov (USA) – https://clinicalinfo.hiv.gov/en/drugs/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate/patient
• View Australian regulatory information from the TGA – https://www.tga.gov.au/resources/section-19a-approvals/efavirenz-emtricitabine-and-tenofovir-disoproxil-fumarate-tablets-600mg200mg300mg-camber-pharmaceuticals-usa
• View Atripla product information from the EMA (Europe) – https://www.ema.europa.eu/en/documents/product-information/atripla-epar-product-information_en.pdf